Vor Biopharma Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | |
| – | +355.0% | +1,424.2% | +220.9% | +101.3% | -61.0% | +1.0% | – | |
| – | – | – | – | – | – | – | – | |
| – | +154.8% | +410.0% | +50.3% | +35.8% | +46.1% | -1.1% | +244.6% | |
| – | +887.6% | +178.6% | +82.9% | +34.3% | +9.9% | -12.1% | +79.8% | |
| – | +261.0% | +320.0% | +59.2% | +22.4% | +45.1% | -1.1% | +206.7% | |
| – | – | – | – | – | – | – | – | |
| – | -39.4% | -100.0% | – | -14.7% | – | – | – | |
| – | – | – | – | – | – | – | – | |
| – | – | -29.7% | -127.8% | – | – | – | – | |
| – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.